COMP <GO>
NUS vs MCK // PIOTROSKI F-SCORE QUALITY
Nu Skin Enterprises Inc. (NYSE) VS. McKesson Corporation (NYSE) • 15-METRIC TALLY: NUS 5
— MCK 5
■ METRIC PARITY
LAST: $4.65 (-0.85%) • MKT CAP: $228.3M
piotroski-score
7/9
LAST: $994.58 (+1.40%) • MKT CAP: $114.36B
piotroski-score
7/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NUS VS. MCK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NUS | MCK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 69.40% | 3.60% | +65.80 | NUS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.70% | 38.60% | -31.90 | MCK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 19.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 20.15% | 5.00% | +15.15 | NUS | /fcf-yield <GO> |
| Operating Margin | 4.40% | 1.50% | +2.90 | NUS | /operating-margins <GO> |
| Net Profit Margin | 10.80% | 1.20% | +9.60 | NUS | /net-margins <GO> |
| Revenue Growth (YoY) | -14.30% | 12.40% | -26.70 | MCK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 5.18% | 0.33% | +4.85 | NUS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.54 | 6.96 | -3.42 | MCK | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.2 | 56.1 | -10.90 | MCK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.95 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 20.2x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $228.3M | $114.36B | -$114.13B | MCK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NUS REV | MCK REV | NUS GROSS % | MCK GROSS % | NUS FCF | MCK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.49B | $403.43B | 69.4% | 3.6% | $46.0M | $5.72B |
| FY 2024 | $1.73B | $359.05B | 68.2% | 3.7% | $70.2M | $5.55B |
| FY 2023 | $1.97B | $308.95B | — | — | $118.6M | -$9.59B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NUS // BETA —
MCK // BETA 0.95